SCL
STEPAN CO
NYSE · Basic Materials · Chemicals - Specialty · US
$70.17
+2.20%Year over year
Reported trailing growth
- Revenue
- +10.0%
- EBITDA
- -19.1%
- EBIT
- +12.8%
- EPS
- -90.4%
- Free cash flow
- -20.9%
- Operating cash flow
- -5.3%
Forward estimates
Based on analyst estimates
- Revenue
- +4.9%
- EBITDA
- +61.2%
- EPS
- +1755.3%
Three-year CAGR
- Revenue
- -5.6%
- EBITDA
- -10.3%
- EBIT
- -30.6%
- Net income
- -31.7%
- EPS
- -31.8%
- Free cash flow
- -35.4%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Sep 1, 2026